MCMCB Pro
J7636

J7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

HCPCSActiveBETOS D1G

J7636 is a HCPCS Level II code for atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J7636 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Compounded Drug Policy
outpatient
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Compounded Drug Policy
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Compounded Drug Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J7636

Long descriptor
Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

The official wording. This is what the code means.

Short descriptor
Atropine comp unit

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2000

When CMS introduced the code.

BETOS
D1G

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J7636

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7636 is not quite right, the correct code is very often within a few positions of it.

  • J7627Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
  • J7628Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7629Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7631Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
  • J7632Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
  • J7633Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
  • J7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
  • J7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
  • J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
  • J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
  • J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

Questions about J7636

What is HCPCS code J7636?

J7636 is a HCPCS Level II code for atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J7636?

The CMS HCPCS file marks J7636 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J7636 paid under the physician fee schedule?

J7636 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026